<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A case of antithrombin-III (AT-III) deficiency was diagnosed on the basis of a diminished <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> effect following the administration of <z:chebi fb="5" ids="28304">heparin</z:chebi> for cardiopulmonary bypass </plain></SENT>
<SENT sid="1" pm="."><plain>The clinical evaluation and interpretation of a diminished response to <z:chebi fb="5" ids="28304">heparin</z:chebi> is discussed, as are considerations relative to the treatment of AT-III deficient persons whose disorder is not manifest until they are already anesthetized for cardiovascular bypass </plain></SENT>
<SENT sid="2" pm="."><plain>The implications of AT-III deficiency relative to the mechanism of <z:chebi fb="5" ids="28304">heparin</z:chebi> rebound are also discussed </plain></SENT>
</text></document>